Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05744869 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

SBAT for Health Equity

StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 2 years later Jul 31, 2030 → Jul 31, 2032
See other at-risk trials from University of Rochester

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Jul 31, 2030 to Jul 31, 2032
    • Start date: Aug 1, 2026 to Jul 1, 2027
    • Study completion pushed from Dec 31, 2030 to Dec 31, 2032
    • Eligibility criteria shortened, about 5 words
  2. Re-verified, no change to tracked fieldsv7
  3. Primary completion date: Jan 31, 2029 to Jul 31, 2030
    • Start date: Aug 1, 2025 to Aug 1, 2026
    • Study completion date: Aug 31, 2029 to Dec 31, 2030
    v6
  4. Eligibility criteria expanded, about 2 words
    • Study description expanded, about 5 words
    v5
  5. Start date: Sep 1, 2024 to Aug 1, 2025v4 Show 4 more changesShow less
    • Study completion date: Jun 30, 2029 to Aug 31, 2029
    • Interventions: Basic Implementation (BI) (Behavioral), Enhanced Implementation (EI) (Behavioral) to SBAT Implementation (Behavioral), Usual Care (Behavioral)
    • Study description shortened, about 269 words
    • Study title shortened, about 1 word
Show 2 earlier versionsHide 2 earlier versions
  1. Start date: Jul 1, 2024 to Sep 1, 2024
    • Eligibility criteria expanded, about 48 words
    v3
  2. Primary completion date: Jun 30, 2028 to Jan 31, 2029v2 Show 7 more changesShow less
    • Start date: Dec 1, 2023 to Jul 1, 2024
    • Primary endpoint revised
    • Study completion date: Nov 30, 2028 to Jun 30, 2029
    • Interventions: SB-CAP (Behavioral) to Basic Implementation (BI) (Behavioral), Enhanced Implementation (EI) (Behavioral)
    • Study description expanded, about 121 words
    • Collaborators: 2 to 3
    • Study title expanded, about 1 word
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this research trial is to: 1) Solidify a population health SBAT implementation strategy with our longstanding community collaborators, 2) Perform a district-wide hybrid type 3, stepped-wedge, cluster randomized trial, and 3) Assess the supportive resource utilization and essential features of SBAT to extend sustainability and fidelity in a cost-effective manner.
Trial Details
NCT Number NCT05744869
Lead Sponsor University of Rochester
Collaborators: Michigan State University, Virginia Polytechnic Institute and State University, University at Buffalo
Conditions
(from sponsor)		 Asthma in Children
Enrollment 300 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov